TSNLF (OTC) is a cross-listing of TSTL.L (LSE). Showing primary listing data.
TSTL.L
Tristel PLC
1W: -2.6%
1M: -9.3%
3M: +3.0%
YTD: -13.5%
1Y: +6.1%
3Y: +29.2%
5Y: -31.4%
£367.66 ($4.91)
-4.84 (-1.30%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap£178.5M ($2.4M)
52W Range260-445
Volume89,197
Avg Volume133,832
Beta0.22
Dividend£14.20
Analyst Ratings
No analyst coverage
Company Info
CEOMatthew Giovanni Sassone
Employees233
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2005-06-01
Websitetristel.com
Lynx Business Park
Newmarket CB8 7NY
GB
Newmarket CB8 7NY
GB
44 16 3872 1500
About Tristel PLC
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.
Latest News
No recent news
Recent Insider Trades
No insider trades found